 | • レポートコード：MRC2303H241 • 出版社/出版日：360iResearch / 2022年10月11日 • レポート形態：英語、PDF、220ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、2021年に1,082.45百万ドルであった世界のNGSベースRNAシーケンシング市場規模が2022年に1,316.58百万ドルとなり、今後は年平均21.88％成長して2027年までに3,549.03百万ドルに達すると予測しています。当書は、NGSベースRNAシーケンシングの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品＆サービス別（データ分析・保存・管理、RNAシーケンシングプラットフォーム・消耗品、RNAシーケンシングサービス、サンプル調製製品）分析、技術別（イオン半導体シーケンシング、ナノポアシーケンシング、合成による配列決定、1分子リアルタイムシーケンシング）分析、用途別（DeNovoトランスクリプトームアセンブリ、発現プロファイリング分析、小分子RNAシーケンシング、バリアントコール＆トランスクリプトームエピジェネティクス）分析、エンドユーザー別（病院＆クリニック、製薬＆バイオテクノロジー企業、研究＆学術機関）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など、以下の構成でまとめております。なお、当書には、Agilent Technologies、Bgi Group、Eurofins Scientific、F. Hoffmann-la Roche Ag、Genewiz、Hamilton Company、Illumina、Nugen Technologies、Oxford Nanopore Technologies、Perkinelmer、Psomagen、Qiagen、Takara Bioなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のNGSベースRNAシーケンシング市場規模：製品＆サービス別 - データ分析・保存・管理の市場規模 - RNAシーケンシングプラットフォーム・消耗品の市場規模 - RNAシーケンシングサービスの市場規模 - サンプル調製製品の市場規模 ・世界のNGSベースRNAシーケンシング市場規模：技術別 - イオン半導体シーケンシングの市場規模 - ナノポアシーケンシングの市場規模 - 合成による配列決定の市場規模 - 1分子リアルタイムシーケンシングの市場規模 ・世界のNGSベースRNAシーケンシング市場規模：用途別 - DeNovoトランスクリプトームアセンブリにおける市場規模 - 発現プロファイリング分析における市場規模 - 小分子RNAシーケンシングにおける市場規模 - バリアントコール＆トランスクリプトームエピジェネティクスにおける市場規模 ・世界のNGSベースRNAシーケンシング市場規模：エンドユーザー別 - 病院＆クリニックにおける市場規模 - 製薬＆バイオテクノロジー企業における市場規模 - 研究＆学術機関における市場規模 ・世界のNGSベースRNAシーケンシング市場規模：地域別 - 南北アメリカのNGSベースRNAシーケンシング市場規模 アメリカのNGSベースRNAシーケンシング市場規模 カナダのNGSベースRNAシーケンシング市場規模 ブラジルのNGSベースRNAシーケンシング市場規模 ... - アジア太平洋のNGSベースRNAシーケンシング市場規模 日本のNGSベースRNAシーケンシング市場規模 中国のNGSベースRNAシーケンシング市場規模 インドのNGSベースRNAシーケンシング市場規模 韓国のNGSベースRNAシーケンシング市場規模 台湾のNGSベースRNAシーケンシング市場規模 ... - ヨーロッパ/中東/アフリカのNGSベースRNAシーケンシング市場規模 イギリスのNGSベースRNAシーケンシング市場規模 ドイツのNGSベースRNAシーケンシング市場規模 フランスのNGSベースRNAシーケンシング市場規模 ロシアのNGSベースRNAシーケンシング市場規模 ... - その他地域のNGSベースRNAシーケンシング市場規模 ・競争状況 ・企業情報 |
The Global NGS-Based RNA-Sequencing Market size was estimated at USD 1,082.45 million in 2021 and expected to reach USD 1,316.58 million in 2022, and is projected to grow at a CAGR 21.88% to reach USD 3,549.03 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the NGS-Based RNA-Sequencing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product & Service, the market was studied across Data Analysis, Storage & Management, RNA Sequencing Platforms & Consumables, RNA Sequencing Services, and Sample Preparation Products. The Sample Preparation Products is further studied across Library Preparation & Target Enrichment, Quality Control, Sample Preparation Products, By Method, and Sample Preparation Products, By Workflow. The Sample Preparation Products, By Method is further studied across Manual Sample Preparation, Microfluidic Sample Preparation, and Robotic Liquid Handling Sample Preparation.
Based on Technology, the market was studied across Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing By Synthesis, and Single-molecule Real-time Sequencing.
Based on Application, the market was studied across De Novo Transcriptome Assembly, Expression Profiling Analysis, Small RNA Sequencing, and Variant Calling & Transcriptome Epigenetics.
Based on End User, the market was studied across Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research & Academia.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for NGS-Based RNA-Sequencing market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the NGS-Based RNA-Sequencing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global NGS-Based RNA-Sequencing Market, including Agilent Technologies, Bgi Group, Eurofins Scientific, F. Hoffmann-la Roche Ag, Genewiz, Hamilton Company, Illumina, Nugen Technologies, Oxford Nanopore Technologies, Perkinelmer, Psomagen, Qiagen, Takara Bio, Thermo Fisher Scientific, and Zymo Research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global NGS-Based RNA-Sequencing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global NGS-Based RNA-Sequencing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global NGS-Based RNA-Sequencing Market?
4. What is the competitive strategic window for opportunities in the Global NGS-Based RNA-Sequencing Market?
5. What are the technology trends and regulatory frameworks in the Global NGS-Based RNA-Sequencing Market?
6. What is the market share of the leading vendors in the Global NGS-Based RNA-Sequencing Market?
7. What modes and strategic moves are considered suitable for entering the Global NGS-Based RNA-Sequencing Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in the adoption of next-generation sequencing
5.1.1.2. Robust growth of precision medicines and rising amount of RNA sequencing grants
5.1.1.3. Increasing demand for advanced sequencing-based diagnostics
5.1.2. Restraints
5.1.2.1. Cost of NGS instruments is high
5.1.3. Opportunities
5.1.3.1. Technological advancement in the RNA-Sequencing
5.1.3.2. Increasing research activities related to RNA-Sequencing
5.1.4. Challenges
5.1.4.1. Unavailability of skilled manpower
5.2. Cumulative Impact of COVID-19
6. NGS-Based RNA-Sequencing Market, by Product & Service
6.1. Introduction
6.2. Data Analysis, Storage & Management
6.3. RNA Sequencing Platforms & Consumables
6.4. RNA Sequencing Services
6.5. Sample Preparation Products
6.6.1. Library Preparation & Target Enrichment
6.6.2. Quality Control
6.6.3. Sample Preparation Products, By Method
6.6.4.1. Manual Sample Preparation
6.6.4.2. Microfluidic Sample Preparation
6.6.4.3. Robotic Liquid Handling Sample Preparation
6.6.4. Sample Preparation Products, By Workflow
7. NGS-Based RNA-Sequencing Market, by Technology
7.1. Introduction
7.2. Ion Semiconductor Sequencing
7.3. Nanopore Sequencing
7.4. Sequencing By Synthesis
7.5. Single-molecule Real-time Sequencing
8. NGS-Based RNA-Sequencing Market, by Application
8.1. Introduction
8.2. De Novo Transcriptome Assembly
8.3. Expression Profiling Analysis
8.4. Small RNA Sequencing
8.5. Variant Calling & Transcriptome Epigenetics
9. NGS-Based RNA-Sequencing Market, by End User
9.1. Introduction
9.2. Hospitals & Clinics
9.3. Pharmaceutical & Biotechnology Companies
9.4. Research & Academia
10. Americas NGS-Based RNA-Sequencing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific NGS-Based RNA-Sequencing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa NGS-Based RNA-Sequencing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Agilent Technologies
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Bgi Group
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Eurofins Scientific
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. F. Hoffmann-la Roche Ag
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Genewiz
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Hamilton Company
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Illumina
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Nugen Technologies
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Oxford Nanopore Technologies
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Perkinelmer
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Psomagen
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Qiagen
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Takara Bio
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Thermo Fisher Scientific
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Zymo Research
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing